Spero Therapeutics Inc. said Vikas Goyal will step down from the company's board.
He will be replaced by David Southwell, who served as president, CEO and director of Inotek Pharmaceuticals from July 2014 until its merger with Rocket Pharmaceuticals Ltd. in January 2018.
Southwell currently serves on the board of PTC Therapeutics Inc. and Rocket Pharmaceuticals.
Cambridge, Mass.-based Spero Therapeutics is developing treatments for multidrug-resistant bacterial infections.
